HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Ellis Selected Research

iodothyronine deiodinase type III (type III deiodinase)

11/2021Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Ellis Research Topics

Disease

21Neoplasms (Cancer)
02/2022 - 10/2011
6Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 11/2017
5Hemorrhage
10/2020 - 01/2016
4Infections
12/2021 - 01/2017
4Venous Thromboembolism
10/2020 - 01/2014
3Anemia
02/2022 - 08/2015
3Thrombophilia
01/2021 - 09/2005
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2018 - 01/2017
3Multiple Myeloma
01/2018 - 08/2014
2Hematologic Neoplasms (Hematological Malignancy)
02/2022 - 12/2021
2COVID-19
12/2021 - 05/2021
2Inflammation (Inflammations)
04/2021 - 07/2020
2Thrombosis (Thrombus)
01/2021 - 07/2020
2Ataxia Telangiectasia (Louis Bar Syndrome)
01/2018 - 11/2017
2Melanoma (Melanoma, Malignant)
01/2018 - 05/2015
2ST Elevation Myocardial Infarction
08/2015 - 01/2015
1Hypertension (High Blood Pressure)
12/2021
1Transfusion Reaction
05/2021
1Splenomegaly
04/2021
1Primary Myelofibrosis (Myelosclerosis)
04/2021
1Carcinogenesis
01/2021
1Placenta Accreta
01/2021
1Disease Progression
07/2020
1Thrombotic Microangiopathies
07/2020
1Hemophilia A (Haemophilia)
07/2020
1Osteonecrosis (Kienbock's Disease)
01/2019
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Rubella (German Measles)
01/2017
1Dyslipidemias (Dyslipidemia)
01/2017
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2016
1Hypoxia (Hypoxemia)
09/2016
1Lung Neoplasms (Lung Cancer)
09/2016
1Renal Insufficiency (Renal Failure)
01/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016
1Hypothyroidism
05/2015
1Hyperthyroidism
05/2015

Drug/Important Bio-Agent (IBA)

15Thyroid HormonesIBA
01/2022 - 10/2011
13IntegrinsIBA
02/2022 - 10/2011
7Proteins (Proteins, Gene)FDA Link
02/2022 - 09/2016
4Thyroxine (Levothyroxine)FDA LinkGeneric
01/2018 - 10/2011
3Hemoglobins (Hemoglobin)IBA
02/2022 - 08/2015
3Triiodothyronine (Liothyronine)FDA LinkGeneric
11/2021 - 08/2014
3EnzymesIBA
11/2021 - 08/2014
3tetraiodothyroacetic acid (TA(4))IBA
01/2018 - 11/2017
2Iodide Peroxidase (Deiodinase)IBA
11/2021 - 01/2021
2Tyrosine Kinase InhibitorsIBA
11/2018 - 01/2018
2Pharmaceutical PreparationsIBA
01/2017 - 08/2006
2Hormones (Hormone)IBA
08/2015 - 10/2011
2Mitogen-Activated Protein KinasesIBA
04/2015 - 10/2011
1remdesivirIBA
12/2021
1iodothyronine deiodinase type III (type III deiodinase)IBA
11/2021
1Oxygen (Dioxygen)IBA
05/2021
1AntibodiesIBA
05/2021
1Bisoprolol (Concor)FDA LinkGeneric
05/2021
1Blood Group Antigens (Blood Groups)IBA
05/2021
1N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
04/2021
1Janus Kinase InhibitorsIBA
04/2021
1IronIBA
04/2021
1Danazol (Azol)FDA LinkGeneric
04/2021
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2021
1Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2021
1Antiphospholipid AntibodiesIBA
01/2021
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2021
1Factor V (Coagulation Factor V)IBA
07/2020
1Hemostatics (Antihemorrhagics)IBA
07/2020
1von Willebrand FactorIBA
07/2020
1AnticoagulantsIBA
07/2020
1Vitamin KFDA Link
01/2020
1Fibrinogen (Factor I)FDA Link
01/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2018
1Phosphotransferases (Kinase)IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1Histones (Histone)IBA
01/2018
13,3',5-triiodothyroacetic acid (Triac)IBA
11/2017
13-iodothyronamineIBA
11/2017
1AcidsIBA
11/2017
1Imatinib Mesylate (Gleevec)FDA Link
01/2017
1Hair DyesIBA
01/2017
1LipidsIBA
01/2017
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2017
1Azacitidine (5 Azacytidine)FDA Link
10/2016
1Lenalidomide (CC 5013)FDA Link
10/2016
1CaspasesIBA
09/2016
1DNA (Deoxyribonucleic Acid)IBA
09/2016
1Daunorubicin (Cerubidine)FDA LinkGeneric
01/2016
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2016
1Biomarkers (Surrogate Marker)IBA
08/2015
1PropylthiouracilFDA Link
05/2015
1RNA (Ribonucleic Acid)IBA
01/2015
1TroponinIBA
01/2015

Therapy/Procedure

3Therapeutics
12/2021 - 01/2016
3Vena Cava Filters (Inferior Vena Cava Filter)
10/2020 - 10/2019
3Drug Therapy (Chemotherapy)
01/2019 - 02/2002
2Critical Care (Surgical Intensive Care)
05/2021 - 11/2016
1Mechanical Ventilators (Ventilator)
05/2021
1Length of Stay
05/2021
1Blood Transfusion (Blood Transfusions)
01/2017
1Erythrocyte Transfusion
01/2016
1Renal Dialysis (Hemodialysis)
01/2016